| |||||||
ShanghaiTech University Knowledge Management System
Spermine alleviates experimental autoimmune encephalomyelitis via regulating T cell activation and differentiation | |
2022-06 | |
发表期刊 | INTERNATIONAL IMMUNOPHARMACOLOGY (IF:4.8[JCR-2023],5.0[5-Year]) |
ISSN | 1567-5769 |
EISSN | 1878-1705 |
卷号 | 107 |
发表状态 | 已发表 |
DOI | 10.1016/j.intimp.2022.108702 |
摘要 | Multiple sclerosis (MS) is a chronic neuroinflammatory disease which causes demyelination, axonal damage and even disability. Th1 and Th17 cells, more precisely, the IFNγ/IL17a double producing CD4 T cells, have been known to play critical roles in the pathogenesis of MS and EAE, a mouse model of MS. Polyamines not only regulate the immune system, but also are essential for the normal function of the central nervous system (CNS). In this study, we demonstrate that the supplementation of spermine (SPM), a biogenic polyamine, significantly suppresses EAE progression in both preventative and therapeutic ways. Further study suggests that spermine significantly reduces IFNγ/IL17a, IFNγ/IL17a and IFNγ/IL17a cells in periphery, and thus reducing the infiltration of these pathogenic cells into the CNS. In vitro, spermine has been shown to suppress the activation and proliferation of CD4 T cells and also significantly impede the polarization of T effector cells in a dose-dependent manner, accompanied by the inhibition of ERK phosphorylation. Consistently, a number of MEK/ERK inhibitors (including PD0325901, FR180204 and selumetinib) have been found to mimic the effects of spermine in inhibiting CD4 T cell activation and T effector cell differentiation. Collectively, spermine alleviates EAE progression by inhibiting CD4 T cells activation and T effector cell differentiation in a MAPK/ERK–dependent manner, suggesting this pathway might be a target to develop effective therapies for MS. |
关键词 | EAE ERK MAPK pathway Multiple Sclerosis Polyamines Spermine Th1 Th17 |
URL | 查看原文 |
收录类别 | SCIE ; SCI |
语种 | 英语 |
资助项目 | National Natural Sci-ence Foundation of China[82121005,81730099] ; Shanghai Science and Technology Commission[TM202101H005] |
WOS研究方向 | Immunology ; Pharmacology & Pharmacy |
WOS类目 | Immunology ; Pharmacology & Pharmacy |
WOS记录号 | WOS:000793198400004 |
出版者 | ELSEVIER |
Scopus 记录号 | 2-s2.0-85126476327 |
来源库 | Scopus |
引用统计 | 正在获取...
|
文献类型 | 期刊论文 |
条目标识符 | https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/165041 |
专题 | 生命科学与技术学院_博士生 生命科学与技术学院_特聘教授组_谢欣组 生命科学与技术学院_硕士生 |
通讯作者 | Xie, Xin |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China 2.Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China 3.China Pharmaceut Univ, Acad Inst Pharmaceut Sci, Nanjing 210009, Peoples R China 4.Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Pharmaceut Sci & Technol, Hangzhou, Peoples R China 5.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China 6.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China |
第一作者单位 | 生命科学与技术学院 |
通讯作者单位 | 生命科学与技术学院 |
推荐引用方式 GB/T 7714 | Zheng, Ruting,Kong, Miaomiao,Wang, Siwei,et al. Spermine alleviates experimental autoimmune encephalomyelitis via regulating T cell activation and differentiation[J]. INTERNATIONAL IMMUNOPHARMACOLOGY,2022,107. |
APA | Zheng, Ruting,Kong, Miaomiao,Wang, Siwei,He, Bingqing,&Xie, Xin.(2022).Spermine alleviates experimental autoimmune encephalomyelitis via regulating T cell activation and differentiation.INTERNATIONAL IMMUNOPHARMACOLOGY,107. |
MLA | Zheng, Ruting,et al."Spermine alleviates experimental autoimmune encephalomyelitis via regulating T cell activation and differentiation".INTERNATIONAL IMMUNOPHARMACOLOGY 107(2022). |
条目包含的文件 | ||||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 |
修改评论
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。